Genocea Biosciences Awarded Grant for the Development of Chlamydia Vaccines from the University of Pittsburgh Medical Center's Sexually Transmitted Infections Cooperative Research Center

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences, a leading vaccine discovery and development company, today announced it has been awarded a grant from the University of Pittsburgh Medical Center’s (UPMC) Sexually Transmitted Infections (STI) Cooperative Research Center for the development of vaccines for Chlamydia trachomatis.

Back to news